- Home
- FSFG vs APLT Comparison
FSFG vs APLT Comparison
Compare FSFG & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSFG
- APLT
- Stock Information
- Founded
- FSFG 2008
- APLT 2016
- Country
- FSFG United States
- APLT United States
- Employees
- FSFG N/A
- APLT N/A
- Industry
- FSFG Savings Institutions
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- FSFG Finance
- APLT Health Care
- Exchange
- FSFG Nasdaq
- APLT Nasdaq
- Market Cap
- FSFG 216.6M
- APLT 178.6M
- IPO Year
- FSFG 2008
- APLT 2019
- Fundamental
- Price
- FSFG $29.69
- APLT $1.01
- Analyst Decision
- FSFG Strong Buy
- APLT Buy
- Analyst Count
- FSFG 3
- APLT 5
- Target Price
- FSFG $31.50
- APLT $4.13
- AVG Volume (30 Days)
- FSFG 19.7K
- APLT 2.6M
- Earning Date
- FSFG 10-29-2025
- APLT 11-10-2025
- Dividend Yield
- FSFG 2.15%
- APLT N/A
- EPS Growth
- FSFG 67.68
- APLT N/A
- EPS
- FSFG 3.32
- APLT N/A
- Revenue
- FSFG $83,825,000.00
- APLT $121,000.00
- Revenue This Year
- FSFG N/A
- APLT N/A
- Revenue Next Year
- FSFG N/A
- APLT $5,935.35
- P/E Ratio
- FSFG $8.96
- APLT N/A
- Revenue Growth
- FSFG 23.11
- APLT N/A
- 52 Week Low
- FSFG $21.63
- APLT $0.30
- 52 Week High
- FSFG $33.00
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- FSFG 47.28
- APLT 45.71
- Support Level
- FSFG $29.18
- APLT $1.08
- Resistance Level
- FSFG $31.17
- APLT $1.24
- Average True Range (ATR)
- FSFG 0.66
- APLT 0.14
- MACD
- FSFG -0.22
- APLT -0.06
- Stochastic Oscillator
- FSFG 25.63
- APLT 9.26
About FSFG First Savings Financial Group Inc.
First Savings Financial Group Inc provides various banking services to individuals and business customers in southern Indiana. The bank accepts deposits from the general public & uses those funds, along with other borrowings, mainly to originate a residential mortgage, commercial mortgage, construction, commercial business, & consumer loans, and to a lesser extent, to invest in mortgage-backed securities and other debt securities. The company conducts lending and deposit activities mainly with individuals and small businesses in its market area. The bank operates in two segments: core banking, which accounts for the majority of revenue, and SBA lending.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.